Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Construction in Progress (2016)

Anika Therapeutics (ANIK) has disclosed Construction in Progress for 6 consecutive years, with $22.7 million as the latest value for Q4 2016.

  • On a quarterly basis, Construction in Progress rose 101.3% to $22.7 million in Q4 2016 year-over-year; TTM through Dec 2016 was $22.7 million, a 101.3% increase, with the full-year FY2016 number at $22.7 million, up 101.3% from a year prior.
  • Construction in Progress was $22.7 million for Q4 2016 at Anika Therapeutics, up from $11.3 million in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $22.7 million in Q4 2016 to a low of $42270.0 in Q4 2012.
  • A 5-year average of $6.9 million and a median of $559000.0 in 2014 define the central range for Construction in Progress.
  • Peak YoY movement for Construction in Progress: tumbled 99.84% in 2012, then skyrocketed 1916.82% in 2015.
  • Anika Therapeutics' Construction in Progress stood at $42270.0 in 2012, then skyrocketed by 272.11% to $157292.0 in 2013, then soared by 255.39% to $559000.0 in 2014, then surged by 1916.82% to $11.3 million in 2015, then skyrocketed by 101.3% to $22.7 million in 2016.
  • Per Business Quant, the three most recent readings for ANIK's Construction in Progress are $22.7 million (Q4 2016), $11.3 million (Q4 2015), and $559000.0 (Q4 2014).